These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27177599)

  • 1. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons centre.
    Cairns R; Brown JA; Buckley NA
    Addiction; 2016 Oct; 111(10):1848-53. PubMed ID: 27177599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.
    Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA
    Med J Aust; 2020 Apr; 212(7):321-327. PubMed ID: 32200566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies.
    Van Hout MC; Norman I
    Int J Drug Policy; 2016 Jan; 27():17-22. PubMed ID: 26454626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codeine use and harms in Australia: evaluating the effects of re-scheduling.
    Cairns R; Schaffer AL; Brown JA; Pearson SA; Buckley NA
    Addiction; 2020 Mar; 115(3):451-459. PubMed ID: 31577369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid exposures in children under 5 years of age (2004-2019): A retrospective study of calls to Australia's largest poisons information centre.
    Arbaeen A; Wheate NJ; Cairns R
    J Paediatr Child Health; 2021 Jun; 57(6):883-887. PubMed ID: 33460248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unintentional mortality associated with paracetamol and codeine preparations, with and without doxylamine, in Australia.
    Hopkins RE; Dobbin M; Pilgrim JL
    Forensic Sci Int; 2018 Jan; 282():122-126. PubMed ID: 29182956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom.
    Tobin CL; Dobbin M; McAvoy B
    Aust N Z J Public Health; 2013 Oct; 37(5):483-8. PubMed ID: 24090333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases.
    Frei MY; Nielsen S; Dobbin MD; Tobin CL
    Med J Aust; 2010 Sep; 193(5):294-6. PubMed ID: 20819050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counting the cost of over-the-counter codeine containing analgesic misuse: A retrospective review of hospital admissions over a 5 year period.
    Mill D; Johnson JL; Cock V; Monaghan E; Hotham ED
    Drug Alcohol Rev; 2018 Feb; 37(2):247-256. PubMed ID: 28925091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of codeine rescheduling on non-opioid analgesic use by people who regularly use codeine: a prospective cohort study.
    Maher J; McCoy J; Bruno R; Nielsen S
    Int J Clin Pharm; 2024 Oct; 46(5):1181-1188. PubMed ID: 39007993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between.
    Nielsen S; Van Hout MC
    Curr Top Behav Neurosci; 2017; 34():59-75. PubMed ID: 26768736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of analgesics following rescheduling of codeine in Australia: An interrupted time series analysis in the veteran population.
    Kalisch Ellett LM; Kemp-Casey A; Kassie GM; Pratt NL; Roughead EE
    Int J Drug Policy; 2020 Jul; 81():102767. PubMed ID: 32416524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data.
    Middleton M; Nielsen S
    Int J Drug Policy; 2019 Dec; 74():170-173. PubMed ID: 31622949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Potential issues of morbidity, toxicity and dependence': Problematizing the up-scheduling of over-the-counter codeine in Australia.
    Weier M; Farrugia A
    Int J Drug Policy; 2020 Jun; 80():102538. PubMed ID: 31362859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and challenges: over-the-counter codeine supply from the codeine consumer's perspective.
    Nielsen S; Cameron J; Pahoki S
    Int J Pharm Pract; 2013 Jun; 21(3):161-8. PubMed ID: 23419000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand.
    McAvoy BR; Dobbin MD; Tobin CL
    N Z Med J; 2011 Nov; 124(1346):29-33. PubMed ID: 22143850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications related to chronic supratherapeutic use of codeine containing compound analgesics in a cohort of patients presenting for codeine withdrawal.
    Cock V; Edmonds C; Cock C
    Drug Alcohol Rev; 2018 Sep; 37(6):731-737. PubMed ID: 29722073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supply of codeine combination analgesics from Australian pharmacies in the context of voluntary real-time recording and regulatory change: A simulated patient study.
    Collins JC; Hillman JM; Schneider CR; Moles RJ
    Int J Drug Policy; 2019 Dec; 74():216-222. PubMed ID: 31677483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs.
    Arora S; Roxburgh A; Bruno R; Nielsen S; Burns L
    Drug Alcohol Rev; 2013 Nov; 32(6):574-81. PubMed ID: 23751176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin and mineral supplement exposures: cases reported to Australia's largest Poisons Information Centre, 2014-2015 to 2018-2019.
    Luckock U; Harnett J; Cairns R
    Br J Nutr; 2021 Dec; 126(12):1788-1793. PubMed ID: 33597065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.